Ubs Group Ag Revolution Medicines, Inc. Transaction History
Ubs Group Ag
- $400 Billion
- Q2 2024
A detailed history of Ubs Group Ag transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 217,763 shares of RVMD stock, worth $10.3 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
217,763
Previous 304,979
28.6%
Holding current value
$10.3 Million
Previous $9.83 Million
14.02%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding RVMD
# of Institutions
232Shares Held
161MCall Options Held
251KPut Options Held
133K-
Vanguard Group Inc Valley Forge, PA14.4MShares$680 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA13.7MShares$646 Million0.1% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$634 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA9.76MShares$462 Million1.83% of portfolio
-
Baker Bros. Advisors LP New York, NY7.57MShares$358 Million3.9% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $4.15B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...